The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression

Oncogene

Volumn 31, Issue 36, 2012, Pages 4012-4021

  Balogh, K ^a   Asa, S L ^a   Zheng, L ^a   Cassol, C ^a   Cheng, S ^a   Ezzat, S ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

cancer progression; Grb14; RET; thyroid cancer

Indexed keywords

ADAPTOR PROTEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 14; INSULIN RECEPTOR; PROTEIN KINASE B; PROTEIN RET; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYROID CANCER; TISSUE MICROARRAY; TUMOR XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; ENZYME ACTIVATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR, INSULIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84866073610     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.569     Document Type: Article

References (30)

1. Asa SL. (2001). How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape. Mod Pathol 14: 246-253.
2. Avantaggiato V, Dathan NA, Grieco M, Fabien N, Lazzaro D, Fusco A et al. (1994). Developmental expression of the RET protooncogene. Cell Growth Differ 5: 305-311.
3. Bai T, Luoh SW. (2008). GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Carcinogenesis 29: 473-479.
4. Bereziat V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J, Burnol AF. (2002). Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. J Biol Chem 277: 4845-4852.
5. Briese J, Ezzat S, Liu W, Winer D, Wagener C, Bamberger AM et al. (2010). Osteopontin expression in thyroid carcinoma. Anticancer Res 30: 111-122.
6. Buckwalter TL, Venkateswaran A, Lavender M, La Perle KM, Cho JY, Robinson ML et al. (2002). The roles of phosphotyrosines-294,-404, and-451 in RET/PTC1-induced thyroid tumor formation. Oncogene 21: 8166-8172.
7. Cheng S, Liu W, Mercado M, Ezzat S, Asa SL. (2009). Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. Endocr Relat Cancer 16: 455-466.
8. Cheng S, Serra S, Mercado M, Ezzat S, Asa SL. (2011). A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res 17: 2385-2394.
9. Cooney GJ, Lyons RJ, Crew AJ, Jensen TE, Molero JC, Mitchell CJ et al. (2004). Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO J 23: 582-593.
10. Daly RJ, Sanderson GM, Janes PW, Sutherland RL. (1996). Cloning and characterization of GRB14, a novel member of the GRB7 gene family. J Biol Chem 271: 12502-12510.
11. de Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM. (2006). RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 27: 535-560.
12. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P et al. (1996). GDNF signalling through the RET receptor tyrosine kinase. Nature 381: 789-793.
13. Engelmann D, Koczan D, Ricken P, Rimpler U, Pahnke J, Li Z et al. (2009). Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance. Endocr Relat Cancer 16: 211-224.
14. Ezzat S, Mader R, Yu S, Ning T, Poussier P, Asa SL. (2005). Ikaros integrates endocrine and immune system development. J Clin Invest 115: 1021-1029.
15. Ezzat S, Zheng L, Zhu XF, Wu GE, Asa SL. (2002). Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109: 69-78.
16. Han DC, Shen TL, Guan JL. (2001). The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20: 6315-6321.
17. Hwang JH, Kim DW, Suh JM, Kim H, Song JH, Hwang ES et al. (2003). Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. Mol Endocrinol 17: 1155-1166.
18. Kasus-Jacobi A, Perdereau D, Auzan C, Clauser E, Van Obberghen E, Mauvais-Jarvis F et al. (1998). Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem 273: 26026-26035.
19. Kondo T, Ezzat S, Asa SL. (2006). Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6: 292-306.
20. Liu W, Wei W, Winer D, Bamberger AM, Bamberger C, Wagener C et al. (2007). CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene 26: 2747-2758.
21. Marchini S, Mariani P, Chiorino G, Marrazzo E, Bonomi R, Fruscio R et al. (2008). Analysis of gene expression in early-stage ovarian cancer. Clin Cancer Res 14: 7850-7860.
22. Margolis B. (1994). The GRB family of SH2 domain proteins. Prog Biophys Mol Biol 62: 223-244.
23. Nouaille S, Blanquart C, Zilberfarb V, Boute N, Perdereau D, Roix J et al. (2006). Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptor. EMBO Rep 7: 512-518.
24. Pandey A, Duan H, Di Fiore PP, Dixit VM. (1995). The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10. J Biol Chem 270: 21461-21463.
25. Pandey A, Liu X, Dixon JE, Di Fiore PP, Dixit VM. (1996). Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7. J Biol Chem 271: 10607-10610.
26. Reilly JF, Mickey G, Maher PA. (2000). Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner. J Biol Chem 275: 7771-7778.
27. Saji M, Ringel MD. (2010). The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors. Mol Cell Endocrinol 321: 20-28.
28. Sullivan I, Chopra A, Carr J, Kim TS, Cohen EP. (2008). Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in mice. Cancer Res 68: 2463-2470.
29. Wang Y, Chan DW, Liu VW, Chiu P, Ngan HY. (2010). Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis. Clin Cancer Res 16: 2529-2539.
30. Yu H, Pardoll D, Jove R. (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809.